Harmony Biosciences Holdings, Inc.
$1.85B- Market cap
- $2.46B
- Debt
- +$163.66M
- Cash
- −$775.34M
Capital structure 94% equity / 6% debt · EV / Revenue 2.13x · EV / EBITDA 7.27x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
HRMY · current priceP/E 15.59x
$42.25Latest market snapshot
Implied fair value · at BAH's multiple
$28.5932.3% below market
2.71 HRMY EPS (TTM)×10.55x BAH P/E=$28.59
Market $42.25Implied $28.59
BAH · current priceP/E 10.55x
$72.80Latest market snapshot
Implied fair value · at HRMY's multiple
$107.5747.8% above market
6.90 BAH EPS (TTM)×15.59x HRMY P/E=$107.57
Market $72.80Implied $107.57